PEOPLE - Xillix (British Columbia) makes appointment:
This article was originally published in Clinica
Executive Summary
Xillix (Richmond, British Columbia), a medical device and diagnostic company specialising in imaging technology for the detection of lung and gastrointestinal cancers, has appointed Robert Sutherland to the board. Dr Sutherland, who has over 35 years of experience in cancer research, currently serves as president of Varian Biosynergy and vice-president of Varian Medical Systems.